The biotech company Peptomyc S.L. announced today that it has been awarded €5 million blended financing from the Horizon Europe, European Innovation Council (EIC) Accelerator Program. The grant will...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreOryzon Genomics, S.A. today announced Last Patient Last Visit in its ongoing Phase IIb PORTICO trial, investigating vafidemstat’s efficacy in Borderline Personality Disorder (BPD). Multiple primary ...
Read moreThis capital increase will allow Kynexis to advance the development of KYN5356, an innovative quinurenine aminotransferase II (KAT-II) enzyme inhibitor, for the treatment of cognitive impairment assoc...
Read moreOxolife, the specialized biotech focused on enhancing embryo implantation in women undergoing Assisted Reproductive Technology (ART) fertility treatment, today announces it has appointed globally reno...
Read moreMineralys Therapeutics today presented data from the Target-HTN Phase 2 trial that further defines an endotype-specific targeted approach for treating uncontrolled or resistant hypertension with lorun...
Read morePeaches Biotech, grupo español de biotecnología especializado en terapias celulares, ha sido galardonado este año como el Proyecto Innovador por el desarrollo de su propia tecnología, basada en el...
Read moreLos investigadores han desarrollado un medicamento dirigido contra la proteína CD98hc, una nueva diana terapéutica presente en la superficie de las células tumorales
Read moreAs part of CALYX, Minoryx is conducting an extensive pre-screening MRI-based campaign aimed at identifying eligible adult X-ALD patients with cerebral Adrenoleukodystrophy (cALD)
Read moreEl mapa revela que 43 socios de AseBio realizan acciones directas dirigidas a combatir la resistencia a los antibióticos por medio de distintas capacidades. La mayoría de estas organizaciones ‘bio...
Read moreThe IBEC is set to lead the coordination of the PHOTOTHERAPORT project, which will be developed with funding from the European Innovation Council’s Pathfinder Open programme. The project focuses on ...
Read moreFunding provided by Nice & Green SA, a Swiss private investor, of €8 million in two tranches of €4 million each, plus optional additional tranches of up to €5 million each to be executed in the ...
Read more